HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent mother-to child transmission: a multi-country cluster-randomized non-inferiority trial (social sciences component)
Objectifs :
The main objective is to evaluate whether a targeted strategy using an innovative point-of-care test in HBV-infected pregnant women followed up at the primary health center level is non-inferior to a universal approach, where all HBV-infected women receive tenovofir (TDF) prophylaxis, in terms of retention in care and reduction in maternal HBV DNA levels at the time of delivery.
The social science component aims to:
- Compare the acceptability, appropriateness, uptake and feasibility of the two strategies.
